Topic: Reuters Group plc
LOS ANGELES (Reuters) - "Rhinestone Cowboy" singer Glen Campbell says he is in the early stages of Alzheimer's disease, and has recorded one last album as a farewell to his fans.Campbell, 75, had been suffering from short-term memory loss for years, but ...
CHICAGO (Reuters) - Scientists have found a way to get antibody-based therapies across a key barrier in the brain and deliver a payload of drugs that take aim at an elusive Alzheimer's target.The researchers at Roche Holding AG's biotechnology unit Genentech said ...
CHICAGO (Reuters) - Brain scans of healthy people showed signs that the brain was shrinking in Alzheimer's-affected areas nearly a decade before the disease was diagnosed, U.S. researchers said on Wednesday.The finding, published in the journal Neurology, may offer a new way ...
CHICAGO (Reuters) - Early studies suggest an experimental Alzheimer's drug attacks free-floating bits of a protein called beta amyloid, a sign the drug may fight what some researchers consider to be the disease's chief culprit.Bapineuzumab, being developed by Pfizer Inc and Johnson ...
LONDON (Reuters) - Britain's health costs agency has confirmed a plan to end restrictions on the use by the National Health Service (NHS) of some Alzheimer's medicines, a change that should allow hundreds of thousands of new patients to get the drugs ...
CHICAGO (Reuters) - Boosting levels of a memory-related protein reversed memory loss in mice with Alzheimer's disease, a finding that could lead to new approaches to treating people, U.S. researchers said on Monday.They said raising levels of CREB-binding protein (CBP) -- a ...
LONDON (Reuters) - Britain's healthcare cost agency plans to end controversial restrictions on Alzheimer's drugs in a policy U-turn that could give hundreds of thousands of patients access to previously denied medicines.The National Institute for Health and Clinical Excellence (NICE) said on ...
CHICAGO (Reuters) - Restoring levels of a nerve-protecting enzyme offers a new approach to developing treatments for Alzheimer's disease, U.S. researchers said on Wednesday.They said the enzyme SIRT1 may help prevent the formation of a toxic form of the protein tau that ...
LONDON (Reuters) - High levels of a blood protein called clusterin are linked to the development of Alzheimer's disease, scientists said on Monday -- a finding which could pave the way for doctors to detect the disease before it takes hold.Researchers from ...
WASHINGTON (Reuters) - Dimebon, a pill being developed as a treatment for Alzheimer's disease, helped people with Huntington's disease improve their thinking, learning and memory skills, U.S. researchers said on Monday.Dimebon, made by Medivation Inc under the generic name latrepirdine, appears to ...
